Hong Kong – Eternal Beauty Holdings Limited announced a RMB97.50 million (HK$110 million) investment to purchase 15 % of Brightday and Dream Biotechnology, operator of the aromatherapy-based skincare brand “AromeManpo”. Eternal (China) International Trading, a wholly-owned subsidiary, signed the capital increase and shareholders’ agreements on 13 April 2026; the first tranche of RMB48.75 million was remitted on 21 April 2026. Post-completion, Eternal Beauty will hold a minority stake of 15 %, while RMB0.80 million will enter registered capital and RMB96.70 million will be booked as capital reserve. All percentage ratios under Chapter 14 of the Listing Rules are below 5 %, so the deal is not a notifiable transaction.
Management expects the investment to strengthen the Group’s presence in high-growth efficacious skincare, leverage its existing distribution network and diversify revenue streams.
In a concurrent update, Eternal Beauty detailed prior service contracts that prompted concerns from former auditor PwC. Between July and September 2025, the Group paid HK$70.00 million in refundable deposits to three third-party service providers (Entity A: HK$40.00 million; Entity B: HK$20.00 million; Entity C: HK$10.00 million). All deposits were fully refunded in November 2025 after the agreements were terminated at PwC’s request.
Regarding the AromeManpo transaction, an earlier HK$30.00 million refundable earnest money was transferred to Entity A in October 2025 under a letter of intent; Eternal Beauty is enforcing its contractual right to reclaim the funds because the acquisition price is now being settled onshore by Eternal PRC.
PwC resigned on 16 March 2026 citing the need for additional procedures and fees; RSM has been appointed auditor for the fiscal year ending 31 March 2026. The company’s investigation committee, supported by external advisers, continues to examine the matters raised. Management states normal operations continue and does not expect the auditor change to delay FY 2026 results.
Trading in Eternal Beauty shares (Stock Code: 06883) has been suspended since 17 March 2026 and will remain halted until further notice. The company will issue further announcements as the investigation progresses and registration of the capital increase is completed.
Comments